| # | Title | Journal | Year | Citations |
|---|
| 1 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up | Journal of the American College of Cardiology | 2020 | 2,392 |
| 2 | Extrapulmonary manifestations of COVID-19 | Nature Medicine | 2020 | 2,300 |
| 3 | Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents | New England Journal of Medicine | 2007 | 1,776 |
| 4 | Bivalirudin during Primary PCI in Acute Myocardial Infarction | New England Journal of Medicine | 2008 | 1,693 |
| 5 | Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic | Journal of the American College of Cardiology | 2020 | 1,557 |
| 6 | Bivalirudin for Patients with Acute Coronary Syndromes | New England Journal of Medicine | 2006 | 1,367 |
| 7 | Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis | Lancet, The | 2007 | 1,329 |
| 8 | Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes | Journal of the American College of Cardiology | 2007 | 776 |
| 9 | Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study | Lancet, The | 2013 | 740 |
| 10 | Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease | JAMA - Journal of the American Medical Association | 2005 | 692 |
| 11 | A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes | Journal of the American College of Cardiology | 2010 | 590 |
| 12 | Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents | JAMA - Journal of the American Medical Association | 2013 | 513 |
| 13 | Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial InfarctionA Randomized Controlled Trial | JAMA - Journal of the American Medical Association | 2005 | 508 |
| 14 | Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data | Lancet, The | 2018 | 506 |
| 15 | Percutaneous Recanalization of Chronically Occluded Coronary Arteries | Circulation | 2005 | 490 |
| 16 | A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 472 |
| 17 | A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock | American Heart Journal | 2006 | 464 |
| 18 | Predictors of blood pressure response in the SYMPLICITY HTN-3 trial | European Heart Journal | 2015 | 458 |
| 19 | Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction | Journal of the American College of Cardiology | 2005 | 451 |
| 20 | Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction | Circulation | 2001 | 439 |
| 21 | Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy | European Heart Journal | 2011 | 427 |
| 22 | Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial | Lancet, The | 2011 | 421 |
| 23 | Use of Drug-Eluting Stents in Acute Myocardial Infarction | Journal of the American College of Cardiology | 2009 | 398 |
| 24 | Infection and Atherosclerosis | Circulation | 1999 | 397 |
| 25 | Secondary Mitral Regurgitation in Heart Failure | Journal of the American College of Cardiology | 2015 | 376 |
| 26 | Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial | Lancet, The | 2009 | 368 |
| 27 | Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial | Lancet, The | 2007 | 367 |
| 28 | Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention | JACC: Cardiovascular Interventions | 2019 | 366 |
| 29 | Staging classification of aortic stenosis based on the extent of cardiac damage | European Heart Journal | 2017 | 364 |
| 30 | Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease | Journal of the American College of Cardiology | 2006 | 342 |
| 31 | Frequency and Distribution of Thin-Cap Fibroatheroma and Ruptured Plaques in Human Coronary Arteries | Journal of the American College of Cardiology | 2007 | 326 |
| 32 | Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial | European Heart Journal | 2009 | 315 |
| 33 | Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention | Journal of the American College of Cardiology | 2012 | 310 |
| 34 | Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis | JACC: Cardiovascular Interventions | 2012 | 305 |
| 35 | Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data | Lancet, The | 2013 | 286 |
| 36 | Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents | Circulation | 2009 | 282 |
| 37 | Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock | American Journal of Cardiology | 2017 | 280 |
| 38 | Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial | Clinical Cardiology | 2012 | 278 |
| 39 | Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes | JAMA - Journal of the American Medical Association | 2007 | 266 |
| 40 | Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis | Circulation | 2004 | 263 |
| 41 | Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! | Catheterization and Cardiovascular Interventions | 2008 | 260 |
| 42 | Long-Term Outcome of Percutaneous Coronary Intervention for Chronic Total Occlusions | JACC: Cardiovascular Interventions | 2011 | 260 |
| 43 | Atherosclerotic Plaque Burden and CK-MB Enzyme Elevation After Coronary Interventions | Circulation | 2000 | 256 |
| 44 | Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction | JAMA - Journal of the American Medical Association | 2015 | 256 |
| 45 | Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions | Journal of the American College of Cardiology | 2017 | 256 |
| 46 | A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan | European Heart Journal | 2015 | 245 |
| 47 | Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents | JAMA - Journal of the American Medical Association | 2006 | 243 |
| 48 | Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction | Journal of the American College of Cardiology | 2011 | 236 |
| 49 | Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology | European Journal of Heart Failure | 2002 | 231 |
| 50 | Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale | American Heart Journal | 2004 | 231 |
